Corebridge Financial’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-38,165
Closed -$1.13M 2690
2025
Q1
$1.13M Sell
38,165
-39
-0.1% -$1.49K 0.01% 1216
2024
Q4
$1.51M Sell
38,204
-2,885
-7% -$109K 0.01% 1134
2024
Q3
$1.4M Sell
41,089
-253
-0.6% -$7.12K 0.01% 1199
2024
Q2
$896K Buy
+41,342
New +$869K ﹤0.01% 1383

Other funds holding VCYT

Corebridge Financial's VCYT Position: Q2 2025 in Review

Corebridge Financial sold out of Veracyte (VCYT) in Q2 2025, closing a stake of 38,165 shares — an estimated $1.13M sold.

Corebridge Financial first reported a position in VCYT in Q2 2024 and held it in 4 quarters. The position peaked at $1.51M in Q4 2024. 278 funds tracked by Wall St. Rank hold VCYT as of Q2 2025.

  • Corebridge Financial reported no remaining Veracyte position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 38,165 Veracyte shares in Q2 2025, an estimated $1.13M.
  • Corebridge Financial first reported a position in Veracyte in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Veracyte position peaked at $1.51M in Q4 2024.
  • 278 funds tracked by Wall St. Rank held Veracyte as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.